Activation of Eosinophil CCR3 Signaling and Eotaxin Using a Bioinformatics Analysis of a Mouse Model of Obliterative Airway Disease

作者: Amrita Dosanjh

DOI: 10.1089/JIR.2013.0100

关键词:

摘要: The role of eosinophils in the development and progression chronic allograft rejection is recognized multiple organ transplantation settings. CCR3 signaling pathway one key regulatory pathways eosinophil migration to engrafted tissue. Eotaxin a ligand for reflects eosinophilic inflammation, which can lead fibrosis. We hypothesized that would be upregulated obliterative airway disease (OAD) an established model rejection. mouse gene microarray data from heterotopic OAD NIH Gene Expression Omnibus (GEO) repository were analyzed differentially expressed pathways, using Partek Suite Ingenuity Pathway Analysis. A P value <0.005 was defined as significant differential expression, <0.05 pathways. Day 25 allografts day 4 acute isografts at showed upregulation (P=0.04), based on analysis 1,299 uniquely genes. compared with those identification 1,859 unique genes, there trend toward over time (P=0.06). not during alloimmune versus comparison, 1,603 by 2.5-fold. eotaxin significantly our results imply controlling early damage controls.

参考文章(13)
S. S. Weigt, A. Derhovanessian, E. Liao, S. Hu, A. L. Gregson, B. M. Kubak, R. Saggar, R. Saggar, V. Plachevskiy, M. C. Fishbein, J. P. Lynch, A. Ardehali, D. J. Ross, H.-J. Wang, R. M. Elashoff, J. A. Belperio, CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction. American Journal of Transplantation. ,vol. 12, pp. 477- 484 ,(2012) , 10.1111/J.1600-6143.2011.03859.X
Kathleen J. Haley, David L. Perkins, Hongzhen He, Rachel DeFina, Scott M. Damrauer, Molecular profiles of allograft rejection following inhibition of CD40 ligand costimulation differentiated by cluster analysis Journal of Leukocyte Biology. ,vol. 71, pp. 348- 358 ,(2002) , 10.1189/JLB.71.2.348
P Khatri, M M Sarwal, A J Butte, Applications of Translational Bioinformatics in Transplantation Clinical Pharmacology & Therapeutics. ,vol. 90, pp. 323- 327 ,(2011) , 10.1038/CLPT.2011.120
Amrita K. Dosanjh, David Elashoff, Adam Kawalek, Richard B. Moss, Silvia Esrig, Activation of Eosinophils in the Airways of Lung Transplantation Patients Chest. ,vol. 112, pp. 1180- 1183 ,(1997) , 10.1378/CHEST.112.5.1180
Martin Zweifel, Christoph Mueller, Thomas Schaffner, Clemens Dahinden, Katja Matozan, Robert Driscoll, Paul Mohacsi, Eotaxin/CCL11 expression by infiltrating macrophages in rat heart transplants during ongoing acute rejection. Experimental and Molecular Pathology. ,vol. 87, pp. 127- 132 ,(2009) , 10.1016/J.YEXMP.2009.07.006
Suzanne Meleg-Smith, Philippe M. Gauthier, Abundance of interstitial eosinophils in renal allografts is associated with vascular rejection. Transplantation. ,vol. 79, pp. 444- 450 ,(2005) , 10.1097/01.TP.0000147318.48620.44
Jianmin Xue, Xuehai Zhu, M. Patricia George, Michael M. Myerburg, Michael W. Stoner, Joseph W. Pilewski, Steven R. Duncan, A Human-Mouse Chimeric Model of Obliterative Bronchiolitis after Lung Transplantation The American Journal of Pathology. ,vol. 179, pp. 745- 753 ,(2011) , 10.1016/J.AJPATH.2011.04.014
Jeffrey D. Lande, Stacy L. Dalheimer, Daniel L. Mueller, Marshall I. Hertz, Richard A. King, Gene Expression Profiling in Murine Obliterative Airway Disease American Journal of Transplantation. ,vol. 5, pp. 2170- 2184 ,(2005) , 10.1111/J.1600-6143.2005.01026.X
A Bouazzaoui, E Spacenko, G Mueller, S Miklos, E Huber, E Holler, R Andreesen, G C Hildebrandt, Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes and Immunity. ,vol. 10, pp. 687- 701 ,(2009) , 10.1038/GENE.2009.49
Andrew K Trull, Fatemeh Akhlaghi, Susan C Charman, Sylvia Endenberg, Oneeb Majid, Jacqueline Cornelissen, Louise Steel, Jayan Parameshwar, John Wallwork, Stephen Large, Immunosuppression, eotaxin and the diagnostic changes in eosinophils that precede early acute heart allograft rejection Transplant Immunology. ,vol. 12, pp. 159- 166 ,(2004) , 10.1016/S0966-3274(03)00077-7